Nancy Lin, MD
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs (NCT06176261) | Nancy Lin, MD | 2024-01-08 |
| Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC (NCT03417544) | Nancy Lin, MD | 2018-05-21 |
Track Nancy Lin, MD automatically
Every clearance here is in the API, with alerts when new ones post.